Advertisement
Screener

Vaxart, Inc. (VXRT) Cash Flow Breakdown

Vaxart, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Vaxart, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-06-30: from running the business, $33.98M came in.
  • Fiscal year ended 2026-06-30: from investing, $7.22M went out.
  • Fiscal year ended 2026-06-30: from financing, $4.06M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backStaff share taxNew shares soldNot split outChange in cash
2026-06-30$33.98M*-$7.22M*-$389.00K*$57.00K*$4.39M*
2025-12-31$7.71M$16.63M-$199.00K$3.00K$4.43M*$28.59M
2025-06-30-$37.09M*$13.83M*-$189.00K*$12.00K*
2024-12-31-$44.76M-$21.32M-$214.00K$30.00K$56.75M*-$9.53M
2024-06-30-$61.74M*$5.39M*-$534.00K*$21.00K*$56.88M*
2023-12-31-$70.45M$43.95M-$366.00K$17.00K$15.59M*-$11.26M
2023-06-30-$85.70M*$8.61M*-$31.00K*$161.00K*$28.77M*
2022-12-31-$94.78M-$20.41M$0.00$17.24M-$97.73M
2022-06-30-$81.09M*-$17.73M*$24.09M*$934.00K*
2021-12-31-$59.83M-$49.10M$122.21M$3.59M*$16.88M
2021-06-30-$49.77M*-$37.72M*$1.38M*$206.99M*
2020-12-31-$23.75M-$1.22M$9.18M$129.14M*$113.34M
2020-06-30-$11.85M*-$149.00K*$9.18M*$30.95M*
2019-12-31-$13.09M-$850.00K$2.54M$13.42M*$2.02M
2019-06-30-$16.03M*-$1.08M*$9.45M*
2018-12-31-$14.55M$26.21M$13.00K-$1.74M*$9.94M
2018-06-30-$12.69M*$47.48M*$34.05M*
2017-12-31-$10.04M$3.18M$24.00K-$6.83M
2017-06-30-$25.72M*$8.40M*$0.00-$32.00M
2016-12-31-$25.60M*$6.90M*-$900.00K*
2016-06-30-$14.10M$1.30M$0.00$17.80M*$5.00M
2015-12-31-$7.20M*-$13.80M*-$21.20M*
2015-06-30-$9.60M-$19.40M$0.00-$29.10M
2014-12-31$700.00K*-$13.00M*$14.50M*
2014-06-30-$3.30M-$10.10M$26.80M$13.40M
2013-12-31-$15.70M*-$700.00K*-$16.40M*
2013-06-30-$13.90M$31.70M$17.80M
2012-12-31-$16.54M*$34.38M*$17.84M*
2012-06-30-$15.90M-$1.30M-$400.00K-$17.60M
2011-12-31-$15.17M$55.25M$663.00K$40.75M
2011-06-30-$33.70M-$700.00K-$34.40M
2011-06-25-$9.52M*$69.86M*$758.00K*-$6.93M*$54.16M*
2010-12-25$39.93M$2.30M-$42.77M-$6.05M$645.00K-$5.95M
2009-12-26$6.22M-$35.64M-$7.94M-$10.09M$528.00K-$46.93M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backStaff share taxNew shares soldNot split outChange in cash
2026-06-30$2.78M*-$2.72M*-$26.00K*$57.00K*
2026-03-31-$2.05M-$676.00K-$338.00K$0.00-$3.07M
2025-12-31$30.66M*$1.99M*-$21.00K*$0.00*$4.30M*
2025-09-30$2.60M*-$5.82M*-$4.00K*$0.00*
2025-06-30-$15.95M*$7.23M*-$7.00K*$0.00*
2025-03-31-$9.60M$13.23M-$167.00K$3.00K$3.47M
2024-12-31-$7.34M*$10.40M*-$6.00K*$0.00*
2024-09-30-$4.20M*-$17.04M*-$9.00K*$9.00K*
2024-06-30-$12.03M*-$9.66M*-$17.00K*$14.00K*$38.24M*
2024-03-31-$21.19M-$5.02M-$182.00K$7.00K$18.37M*-$8.02M
2023-12-31-$13.52M*$15.10M*-$327.00K*$0.00*
2023-09-30-$15.00M*$4.97M*-$8.00K*$0.00*
2023-06-30-$17.47M*-$1.58M*-$21.00K*$17.00K*$13.90M*
2023-03-31-$24.46M$25.46M-$10.00K$1.43M$2.42M
2022-12-31-$29.15M*$15.80M*$0.00*$8.59M*
2022-09-30-$14.62M*-$31.07M*$0.00*$4.85M*
2022-06-30-$25.90M*-$8.88M*$0.00*$2.81M*
2022-03-31-$25.11M$3.73M$0.00$992.00K-$20.34M
2021-12-31-$15.81M*-$8.18M*$0.00*$505.00K*
2021-09-30-$14.27M*-$4.41M*$20.30M*
2021-06-30-$13.16M*-$15.95M*$36.20M*$861.00K*
2021-03-31-$16.59M-$20.56M$65.71M$1.88M*$30.44M
2020-12-31-$10.77M*-$902.00K*$200.00K*$4.90M*
2020-09-30-$9.26M*-$308.00K*$286.00K*$98.33M*
2020-06-30-$521.00K*-$9.00K*$98.00K*$14.96M*
2020-03-31-$3.21M-$1.00K$9.18M$10.37M*$16.33M
2019-12-31-$3.79M*-$12.00K*$0.00*-$2.23M*
2019-09-30-$4.33M*-$127.00K*$0.00*$7.75M*
2019-06-30-$317.00K*-$159.00K*$0.00*$8.31M*
2019-03-31-$4.65M-$552.00K$2.54M-$3.08M
2018-12-31-$5.70M*-$195.00K*$0.00*-$519.00K*-$6.42M*
2018-09-30-$5.36M*-$173.00K*$0.00*-$6.00M*
2018-06-30$7.10M*-$199.00K*$0.00*$6.43M*
2018-03-31-$10.59M$26.78M$13.00K$15.92M
2017-12-31-$4.70M*$14.50M*$9.80M*
2017-09-30-$4.50M$6.40M$1.90M
2017-06-30-$1.75M*$1.05M*$0.00*-$700.00K*
2017-03-31-$4.28M-$844.00K-$5.12M
2016-12-31-$9.00M*$1.30M*-$7.80M*
2016-09-30-$10.70M$6.90M-$3.80M
2016-06-30$1.10M*$0.00*$18.00M*$19.10M*
2016-03-31-$7.00M*-$1.30M*-$8.40M*
2015-12-31-$9.10M*$2.80M*-$6.30M*
2015-09-30$900.00K-$200.00K$0.00$600.00K
2015-06-30$200.00K*-$16.70M*-$16.60M*
2015-03-31$800.00K*$300.00K*$1.10M*
2014-12-31$1.00M*$6.90M*$7.90M*
2014-09-30-$11.60M-$9.90M-$21.50M
2014-06-30$10.60M*-$9.90M*$0.00*$700.00K*
2014-03-31$700.00K*-$100.00K*$27.40M*
2013-12-31-$8.40M*$0.00*-$8.40M*
2013-09-30-$6.20M-$100.00K-$6.30M
2013-06-30$2.50M*-$500.00K*$2.00M*
2013-03-31-$3.60M*-$100.00K*-$3.70M*
2012-12-31-$7.60M*$32.50M*$24.90M*
2012-09-30-$5.20M-$200.00K-$5.40M
2012-06-30-$2.23M*-$1.00K*-$2.23M*
2012-03-31-$1.51M$2.08M$565.00K
2011-12-31-$707.00K*$2.05M*$17.00K*$1.36M*
2011-09-24-$5.43M*$11.64M*$121.00K*$6.33M*
2011-06-25-$428.00K*$27.72M*$230.00K*$27.53M*
2011-03-26-$8.60M$13.84M$295.00K$5.53M
2010-12-25-$1.55M*$17.60M*-$5.00K*$0.00*$232.00K*$16.28M*
2010-09-25$1.06M*$10.69M*-$6.92M*$0.00*$1.00K*$4.83M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
Pelthos Therapeutics Inc. (PTHS)United States$0.086B-1.20
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
EXOZYMES INC. (EXOZ)United States$0.058B